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ABSTRACT
Background In The Netherlands, health professionals
have created a doctor-driven standardised system to
report and analyse adverse outcomes (AO). The aim is to
improve healthcare by learning from past experiences.
The key elements of this system are (1) an unequivocal
deﬁnition of an adverse outcome, (2) appropriate
contextual information and (3) a three-dimensional
hierarchical classiﬁcation system.
Objectives First, to assess whether routine doctor-
driven AO reporting is feasible. Second, to investigate
how doctors can learn from AO reporting and analysis to
improve the quality of care.
Methods Feasibility was assessed by how well doctors
reported AO in the surgical department of a Dutch
university hospital over a period of 9 years. AO incidence
was analysed per patient subgroup and over time, in
a time-trend analysis of three equal 3-year periods. AO
were analysed case by case and statistically, to learn
lessons from past events.
Results In 19907 surgical admissions, 9189 AOs were
reported: one or more AO in 18.2% of admissions. On
average, 55 lessons were learnt each year (in 4.3% of
AO). More AO were reported in P3 than P1 (OR 1.39
(1.23e1.57)). Although minor AO increased, fatal AO
decreased over time (OR 0.59 (0.45e0.77)).
Conclusions Doctor-driven AO reporting is shown to be
feasible. Lessons can be learnt from case-by-case
analyses of individual AO, as well as by statistical
analysis of AO groups and subgroups (illustrated by time-
trend analysis), thus contributing to the improvement of
the quality of care. Moreover, by standardising AO
reporting, data can be compared across departments or
hospitals, to generate (conﬁdential) mirror information for
professionals cooperating in a peer-review setting.
Most studies on medical adverse outcomes (AO)
rely on retrieval and reconstruction of events from
patients’ records by trained reviewers.
1e6 Such
approaches have limited effectiveness for quality
assessment and improvement. First, retrospective
retrieval suffers from the fact that valuable
contextual information may be lost when data
collection occurs long after the actual medical
treatment. Second, older studies often focus on
negligence or the type of injury inﬂicted, and not
on learning from past events.
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What is needed, and cannot be delivered by
retrospective studies, is a system that encourages
healthcare providers to report AOs routinely and
then gives immediate and meaningful feedback by
which doctors can learn from past events. With
these aims in mind, the Dutch Order of Medical
Specialists set nationwide standards to create
a doctor-driven system of AO reporting that is
integrated into routine clinical care. Its key
elements are (1) an unambiguous deﬁnition of what
constitutes an AO, (2) a minimum set of contextual
data needed for analysis, and (3) a classiﬁcation
system that organises AOs into clinically and
causally relevant groups and subgroups.
The present study elucidates the principles and
methods of this system, assesses its advantages and
limitations and illustrates its clinical use in the
surgical department of a Dutch university hospital.
PATIENTS AND METHODS
A standardised AO reporting system has been in use
at the Department of Surgery of the Leiden
University Medical Centre since 1997. It is used on
all patients who were admitted to, or under the
responsibility of, the Department of Surgery, and
on patients admitted to non-surgical departments
who were operated by a surgeon (or an intern or
a resident). Each weekend, a software routine of the
Leiden University Medical Centre hospital infor-
mation system retrieves patients meeting the above
surgical criteria who had been discharged in the
week that ended 2 weeks before that weekend. The
surgical procedures that these patients underwent
cover the whole of general surgery, ranging from
endocrine, gastrointestinal, oncological, transplant,
trauma, to vascular surgery.
DEFINITION OF ADVERSE OUTCOME
In The Netherlands, an “adverse outcome” is
deﬁned as:
“. an unintended and unwanted event or state
occurring during or following medical care, that is so
harmful to a patient’s health that (adjustment of)
treatment is required or that permanent damage
results. The adverse outcome may be noted during
treatment or in a predeﬁned period after discharge or
transfer to another department. The intended results
of treatment, the likelihood of the adverse outcome
occurring and the presence or absence of a medical
error causing it, are irrelevant in identifying an
adverse outcome.”
The Dutch deﬁnition of an AO is more sensitive
than the deﬁnitions used in retrospective studies in
that those deﬁnitions excluded the consequences of
the disease itself and/or co-morbidity.
1e3 Using
ad e ﬁnition with such exclusion rules in routine
reporting would require a doctor to completely
understand the cause of an AO and its prevent-
ability and/or blame. The Dutch deﬁnition obviates
such judgement, with the aim of reducing subjec-
tivity and inter-observer variability and thereby
facilitating comparisons over time and/or across
different settings.
< An additional appendix is
published online only. To view
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Original researchMANAGEMENT OF (CONTEXTUAL) INFORMATION
A special software was designed to support the management of
hospital information system and AO data. All the patients
identiﬁed by the hospital information system search were
automatically imported each week into an AO database (Access
2003) with a minimum dataset of contextual information,
including name, gender, date of birth, operative procedures
performed and the American Society of Anesthesiologists (ASA)
classiﬁcation. Operative procedures were automatically classiﬁed
with respect to technical complexity, according to the standards
of the Association of Surgeons of The Netherlands (on a scale
ranging from 1 for simple to 5e7 for complex or difﬁcult surgical
procedures).
The occurrence or non-occurrence of all AO was recorded on
paper for all patients. Selected AOs were checked and discussed
at weekly meetings attended by surgeons, residents and interns
and chaired by a staff surgeon. The selection of AOs was based
on an algorithm that included patients (1) with three or more
AOs, (2) with one or more AOs leading to reoperation, perma-
nent damage and/or death (ie, grade 2 or higher; see below) or (3)
with an AO report that seemed likely to contain a lesson for the
future. The aim of the above selection was to ensure interesting
meetings and thus maximise attendance. Each patient with an
AO was presented by the intern/resident who was on the ward
when the patient was discharged. The focus of the ensuing
discussion was to interpret the underlying causes and thus learn
how other such outcomes might be prevented. After the
meeting, data forms of all patients, without and with AOs,
discussed and non-discussed, are entered into the AO database
using the software described above. Patients with one or more
AOs are the denominator of the proportion of patients with an
AO, the whole patient set being the numerator.
MASTER CLASSIFICATION
AOs were classiﬁed according to a special classiﬁcation system
that was designed to match existing (inter)national classiﬁcation
systems as closely as possible. This “master classiﬁcation”
facilitated analysis by allowing AO to be automatically aggre-
gated (by the software) into speciﬁc groups and subgroups, The
master classiﬁcation system deﬁnes the key characteristics of
each AO in terms of the following three dimensions (see online
Appendix A):
1. Type of AO that is its pathology (eg, infection, bleeding)
2. Location, speciﬁed by
a. region (eg, thorax, abdomen) and/or by
b. organ or organ system (eg, lung, liver) and/or by
c. tissue
3. Contextual information and potential determinants (eg,
medication).
The ﬁrst dimensiondtypedis based on the International Clas-
siﬁcation of Diseases, 10th revision, but with adaptations to
accommodate AOs (as opposed to spontaneous disease). The
second dimensiondlocationdis based on the Dutch WCC Stan-
dard Anatomical Location (http:www.rivm.nl/who-ﬁc/Annuals/
Paris26.pdf), developed by WHO. Of the various elements that fall
undercontextualinformationdimension,thecodingofmedication
was derived from the Anatomical Therapeutic Chemical classiﬁ-
cation (http://www.whocc.no/atc_ddd_publications/guidelines/).
Each dimension comprises two or more degrees of detail, to allow
general and detailed analyses. AOs were graded according to four
levels of severity: (1) temporary health disadvantage, recovery
without (re)operation; (2) recovery after (re)operation; (3) (prob-
ably) permanent damage or function loss; and (4) death.
Analysis
AOs were analysed in two ways: by discussion of individual
patients at weekly AO meetings and by regular statistical
analysis of patient groups and subgroups.
1. Individual patients were discussed at by means of four
structured questions shown below (table 1). The answers
given provided (interpretational) information on determi-
nants and preventability. All answers generated since 2003
have been stored in a second database. Lessons learnt can lead
to quality improvement on for individual patients and for
similar patients in the future.
2. The statistical analysis of the groups and subgroups was
performed at regular intervals, at least once a year or
whenever deemed necessarydfor example, a clinical query
or a research question. Logistic regression analysis was used
to study the relation between patient mix and operation mix
on the one hand, and the incidence of (admissions with) AOs
on the other. Patient-mix characteristics were age at
admission, gender, and anaesthetic risk proﬁle (high risk
being deﬁned as ASA 3 or higher at ﬁrst operation).
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operation mix consisted of various degrees of surgical
technical complexity or difﬁculty.
For the analysis of time trends, the total study period of
9 years was subdivided into three equal periods (P1: 1997e1999,
P2: 2000e2002 and P3: 2003e2005), which allowed for a more
robust analysis than analysis per year. Logistic regression anal-
ysis was carried out for all 18 types of AOs and for each of the
four grades of severity. The number of AOs per subset divided by
the number of all AOs was taken to be an indicator of a subset’s
contribution to the overall trend. If the incidence of a speciﬁc
type of AO changed/increased signiﬁcantly over time to such an
extent that it contributed more than 5% of all AOs, further
analysis was performed to identify which subgroups within that
category, deﬁned on the second or third dimension, contributed
most to the observed time trend.
In all analyses, signiﬁcance was determined by p values
smaller than 0.01, given the large number of patient admissions.
RESULTS
Over the 9-year study period, 19907 patient admissions met the
inclusion criteria for surgical AO reporting. For all these admis-
sions, the absence or occurrence of AOs was documented and
veriﬁed. Mean patient age at admission was 46.7 (21.9) years,
47.5% of patients were women, 18.5% were ASA 3 or higher and
29.9% underwent “complex” surgery (see table 2). A total of
9189 AOs were reported, with one or more AOs occurring in
18.2% of admissions (table 2).
Table 1 The four main questions that guide weekly discussions on
adverse outcomes
1. What are consequences for patient and care?
< Severity (four-level scale)dintensity and cost of care
2. What is the complication’s main determinant?
< Targeted disease/co-morbidity/surgery/treatment otherwise
3. In retrospect; could it have been avoided and how?
< By other treatment choice/execution/pre-care or after-care/.
BIf so, then why was this not done?
-Because of pros and cons of alternatives/risk assessment/simply
“wrong”
4. Prospectively: what is the lesson learnt?
< There is none; the complication is “all in the game”
BThen what was the risk?
5. Did the patient know, and how do we know he/she did?
< Yes, there is a “Lesson”!
BThen what precisely went wrong, and what should be corrected for the
future, how, when and by whom?
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meetings. Most AOs were deemed to be related to operative
treatment (42.5%), followed by non-surgical treatment (29.4%),
primary disease (14.5%) and co-morbidity (13.5%). From 2003 to
2005 (P3), 20.9% of all AOs were considered (potentially)
avoidable and 4.3% led to speciﬁc “lessons learnt”; that is, an
average of 55 lessons per year.
Older patients had more AOs, as did high-risk patients and
patients undergoing complex surgery (table 3). The overall
incidence of reported AOs increased over time (table 3), AO
incidence being 39% higher in P3 than in P1, mainly because of
an increase in minor AOs (severity category 1, see table 4). The
incidence of AOs of severity category 4 (death of the patient)
decreased by 40% between 1997 and 2005.
Investigation of AO types showed that 7 out of 18 main-type
categories occurred more frequently in P2 and/or P3 than in P1.
The two categories that occurred most frequently (indicated in
bold in table 5) were “inﬂammation/infection” and “functional
disorders” (29% and 23%, respectively; other categories only
7%).
Investigation of AO location showed that AOs of the
abdomen, leg (table 6) and circulatory tract (table 7) contributed
most to the observed increase in “inﬂammation/infection”.
Investigation of the third dimensiondcontextdrevealed that
wound infections increased signiﬁcantly (odds ratio (OR) 1.54
(1.20e1.98) for P3 vs P1) and accounted for 27% of the overall
infection increase. Circulatory tract infections, in particular
those related with the use of vascular catheters, likewise
increased (OR 2.97 (1.51e5.82) in P3 compared with P1) but
contributed only 4.4%.
The increase in “functional disorders” was mainly explained
by a signiﬁcant increase in functional disorders of the kidney
(OR 2.32 (1.52e3.52) for P3 vs P1, and contributing 12.8% of
functional disorders), and by medication-related functional
disorders (OR 2.32 (1.06e5.06) for P3 vs P1).
DISCUSSION
The present study demonstrates that doctor-driven reporting of
AO is feasible alongside routine clinical care over a long period.
Even after adjusting for shifts in patient mix and operation mix,
it was seen that the number of non-serious AO reported
increased rather than decreased, whereas the number of deaths
(severity 4 AO) decreased. This suggests that the reporting of
AO has become increasingly sensitive over time and that surgical
care has become safer with respect to mortality. AO reporting
was used to support professionals in assessing and improving
their own quality of care in two ways. First, through the weekly
AO meetings, surgeons discuss and analyse AOs that their
patients suffered case by case. The emphasis lies on ‘What can
we learn from this?’ instead of on‘What have they done wrong?’.











Mean (SD) n % %
1997 2315 47.3 (20.8) 48.2 14.6 30.3 343 14.7 15.8
1998 2203 46.7 (21.2) 49.2 15.4 26.2 332 15.1
1999 2059 45.9 (21.5) 46.8 15.3 27.3 361 17.5
2000 2008 47.6 (21.4) 46.3 20.7 30.2 368 18.3 17.3
2001 1906 47.1 (21.9) 49.2 21.2 31.0 317 16.6
2002 2196 46.0 (22.7) 46.7 20.7 31.2 373 17.0
2003 2173 45.7 (22.8) 46.3 22.4 29.9 417 19.2 21.3
2004 2467 46.0 (22.2) 46.4 20.8 30.1 517 21.0
2005 2580 47.8 (22.2) 48.4 16.5 32.2 603 23.4
All 19907 46.7 (21.9) 47.5 18.5 29.9 3631 18.2
Table 3 Incidence of registered adverse outcomes in
surgical patients over time
Variable OR (99% CI)*
Year of discharge (reference¼1997, with OR 1.00)
1998 1.05 (0.84 to 1.32)
1999 1.29 (1.03 to 1.62)
2000 1.21 (0.97 to 1.52)
2001 1.05 (0.84 to 1.33)
2002 1.13 (0.91 to 1.42)
2003 1.34 (1.08 to 1.67)
2004 1.54 (1.25 to 1.89)
2005 1.71 (1.40 to 2.10)
Age (per life-year) 1.03 (1.03 to 1.03)
Gender (female/male) 0.87 (0.78 to 0.96)
ASA classy
ASA class 3-5 2.42 (2.16 to 2.72)
ASA class missing 1.51 (1.25 to 1.82)
High surgical complexity 1.82 (1.64 to 2.02)
ASA, American Society of Anesthesiologists.
Model ﬁt: Nagelkerke R
2¼0.171.
*Signiﬁcant differences (p<0.01) are indicated in bold.
yReference: ASA class 1e2.
















0.98 (0.86 to 1.12) 1.40 (1.24 to 1.58) 70.1
2 Recovery after
(re)operation
1.13 (0.93 to 1.38) 1.16 (0.96 to 1.41) 21.6
3 (Probably) permanent
damage or function loss
1.28 (0.84 to 1.94) 1.36 (0.91 to 2.03) 3.1
4 Death 0.72 (0.55 to 0.94) 0.59 (0.45 to 0.77) 5.1
All adverse outcomes 1.03 (0.90 to 1.17) 1.39 (1.23 to 1.57) 100
In this table, and in tables 5e7, results were adjusted for age, sex, American Society of
Anesthesiologists classiﬁcation and surgical complexity. All ORs are provided with 99% CI
(99% CI). Groups of adverse outcomes that changed signiﬁcantly (p<0.01) over time and
contributed more than 5% to the overall incidence are indicated in bold.
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period, and applied to many areas ranging from thrombosis
prophylaxis in subgroups of patients to technicalities of fracture
management at the operating room, and from the appropriate
use of antibiotics in trauma patients to timing and preoperative
workup of liver transplant patients. Second, at a group level, the
aggregation of AOs into master classiﬁcation groups makes it
possible to carry out a statistical analysis of AOs and possible
determinants, independent of the weekly case-by-case analyses.
As an example, the time-trend analysis presented here demon-
strates a signiﬁcant increase in functional disorders of the
kidney, which is most likely related to new immune-modulating
drugs used in transplantation and an increase in reported
infections. A detailed analysis of the latter has been published in
a separate paper.
9 Infections identiﬁed by AO reporting differ
from those identiﬁed by monitoring of the Centers for Disease
Control and Prevention, as AO reporting includes all suspected
or proven infections that do not resolve without treatment, that
is, that require(d) treatment or have been treated. Apart from
the fact that infection monitoring by the Centers for Disease
Control and Prevention is not ubiquitous in all Dutch hospitals,
it does not routinely provide detailed information on context or
potential causes.
Outside the context of the registering department or hospital,
doctor-driven AO reporting can also be used for “mutual moni-
toring”. When professionals from different departments or
hospitals cooperate through a (conﬁdential) national AO data-
base, this can provide mirror information to allow doctors to
compare their own AO data with anonymous AO data that have
been collected by professionals working in similar hospitals or
departments. For such a purpose, the system described here has
been adopted as the national standard for AO reporting by the
Association of Surgeons of The Netherlands. Obviously, addi-
tional important issues will need to be addressed, such as
adjusting for under-reporting and for more detailed differences in
patient and operation mix, to further improve the validity of
mirror comparisons.
The Dutch Healthcare Inspectorate analyses the quality of
care of all Dutch hospitals annually through national “external”
benchmarking of a set of 20 quality performance indicators. One
of these indicators is whether medical professionals and hospital
departments practice AO reporting. The Inspectorate has, in line
with recommendation 6.1 of the Institute of Medicine report
“To err is human”
i on peer-review protections, stated that AO
data are and will at all times remain the sole property of the
medical professionals and will never directly be used for
benchmarking. However, if professionals are found to have out-
of-range performance indicators, they themselves can use the
detailed information provided by the AO reporting system to
bring their performance up to standard.
Other research has been published on how to make healthcare
safer.
10e12 Chang et al
13 proposed a standardised terminology
and classiﬁcation for adverse events. The approach presented
here differs from Chang et al’s in that it is not limited to













1.68 (0.88 to 3.23) 2.03 (1.09 to 3.76) 1.3
Bleeding/haematoma 0.79 (0.60 to 1.05) 0.90 (0.69 to 1.17) 7.4
Pressure sore 0.88 (0.44 to 1.74) 0.92 (0.48 to 1.77) 1.1
Fistula 2.06 (0.93 to 4.55) 2.41 (1.13 to 5.12) 1.3
Functional disorder 0.97 (0.80 to 1.18) 1.27 (1.06 to 1.52) 22.9
Ischaemia 1.15 (0.61 to 2.16) 1.54 (0.86 to 2.76) 1.3
Symptoms without diagnosis 1.52 (1.03 to 2.25) 2.27 (1.58 to 3.25) 4.4
Injury by mechanical/physicalechemical
cause
0.97 (0.71 to 1.34) 1.16 (0.86 to 1.56) 5.0
Necrosis/Infarction 1.63 (1.11 to 2.40) 1.21 (0.82 to 1.79) 3.8
Inﬂammation/infection 1.05 (0.89 to 1.25) 1.32 (1.13 to 1.54) 28.7
Psychological disturbance 2.03 (1.18 to 3.46) 2.32 (1.39 to 3.89) 2.2
Procedure with speciﬁed unintended
substandard outcome
0.35 (0.14 to 0.86) 0.48 (0.22 to 1.03) 0.7
Shock 0.94 (0.69 to 1.28) 1.04 (0.77 to 1.40) 5.1
Thrombosis/embolus 1.20 (0.78 to 1.85) 1.30 (0.86 to 1.97) 2.4
Accumulation/leakage of body ﬂuids 1.01 (0.75 to 1.36) 1.26 (0.95 to 1.66) 6.2
Wound healing 1.34 (0.93 to 1.95) 1.38 (0.96 to 1.98) 3.9
Other/non-speciﬁed 0.71 (0.47 to 1.05) 0.94 (0.65 to 1.34) 2.2
All adverse outcomes 1.03 (0.90 to 1.17) 1.39 (1.23 to 1.57) 100
*The main contributing groups of adverse outcomes are analysed further by localisation (tables 6 and 7).










Per cent of total
number of
infections
Head 1.26 (0.42 to 3.74) 1.67 (0.61 to 4.56) 1.6
Neck 2.02 (0.56 to 7.36) 3.37 (1.03 to 11.00) 1.5
Back 1.79 (0.19 to 16.79) 1.18 (0.11 to 12.51) 0.3
Thorax 1.02 (0.74 to 1.40) 1.11 (0.82 to 1.50) 18.0
Abdomen 1.19 (0.90 to 1.58) 1.37 (1.06 to 1.79) 30.0
Pelvis 0.91 (0.67 to 1.24) 1.22 (0.92 to 1.60) 20.0
Arm 1.46 (0.55 to 3.87) 1.81 (0.73 to 4.51) 1.9
Leg 1.40 (0.84 to 2.34) 2.33 (1.47 to 3.70) 8.5
Other/non-
speciﬁed
0.98 (0.70 to 1.38) 1.05 (0.76 to 1.45) 18.2
All infections 1.05 (0.89 to 1.25) 1.32 (1.13 to 1.54) 100
iSee Recommendation 6.1. Congress should pass legislation to extend peer-review
protections to data related to patient safety and quality improvement that are
collected and analysed by healthcare organisations for internal use or shared with
others solely for purposes of improving safety and quality.
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process. By eliminating causality, such as errors, as a criterion for
reporting, the “Dutch approach” is more sensitive and has less
observer-dependent reporting. In addition, it provides informa-
tion about all AO and is thus a more relevant source of infor-
mation because it does not exclude AOs that are not caused by
errors. The fact that Dutch AO reporting is integrated into
routine clinical practice has advantages over other initiatives
that are not rooted in routine patient management, such as the
National Conﬁdential Enquiry into Patient Outcome and
Death.
14 15 Not the least of these advantages are the regular
plenary discussions among clinicians and the lessons learnt
directly each week.
Doctor-driven reporting inevitably has drawbacks as well, the
most obvious being underreporting. However, we have shown in
an earlier study that, with the overriding focus on learning,
underreporting can be kept to a minimum.
The internal monitoring described here, and the mutual
monitoring, which is presently part of an initiative in The
Netherlands, demonstrate that doctor-driven AO reporting can
be a powerful instrument with the potential to prevent AO in
patients in the future.
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Other/non-speciﬁed tract 1.23 (0.96 to 1.56) 1.65 (1.32 to 2.06) 44.1
All infections 1.05 (0.89 to 1.25) 1.32 (1.13 to 1.54) 100
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